Evolution of the Average Target: IMAX Corporation

Evolution of the Target Price: IMAX Corporation

Changes in Analyst Recommendations: IMAX Corporation

2f82da7d783cd0717b9.Ektw3cbqix7gKKAGcRJHdH7hpr9H-of8IW_FLlXYBqM.eRQhn5K_0VqoeZZkRXYqJRWVyuUJiunERxywXxKhR_MmJgW6oafsRoxy9Q~9c1bfce2321f3f0d3dfbea18e314885c
24/08 B. Riley Adjusts IMAX Price Target to $61 From $52, Maintains Buy Rating MT
25/07 IMAX Q2 Results Reinforce Long-Term Growth Outlook, Wedbush Says MT
25/07 Barrington Research Adjusts IMAX Price Target to $50 From $46, Maintains Outperform Rating MT
24/07 B. Riley Adjusts Price Target on IMAX to $52 From $48, Maintains Buy Rating MT
24/07 Wedbush Adjusts Price Target on IMAX to $54 From $46, Maintains Outperform Rating MT
17/07 IMAX's H2 Outlook Remains Strong Despite Modest Q2 Growth, Wedbush Says MT
16/07 Wells Fargo Downgrades IMAX to Equalweight From Overweight, Cuts Price Target to $41 From $47 MT
10/07 B. Riley Adjusts IMAX Price Target to $48 From $46, Maintains Buy Rating MT
19/05 IMAX on Track to Reach $1.4 Billion in Box Office Proceeds Despite Headwinds, B. Riley Says MT
04/05 Barrington Raises Price Target on IMAX to $46 From $42, Keeps Outperform Rating MT
02/05 IMAX is Poised to Surpass 50% EBITDA Margins by 2028 on Rise in Filmed-for-IMAX Titles, Wedbush Says MT
24/04 IMAX's Global Film Slate Likely to Support 'Robust' 2026, Wedbush Says MT
18/04 B. Riley Upgrades 2026 Box Office Outlook Following First-Quarter Beat MT
27/02 Macquarie Raises Price Target on IMAX to $45 From $44, Keeps Outperform Rating MT
27/02 IMAX Poised to Benefit from Multiple Factors, Wedbush Says MT
27/02 B. Riley Adjusts Price Target on IMAX to $46 From $44, Maintains Buy Rating MT
16/12 JPMorgan Upgrades IMAX to Overweight From Neutral, Adjusts Price Target to $47 From $32 MT
09/12 IMAX EBITDA Margins Seen Surpassing 50% by 2028, Wedbush Says MT
09/12 Wedbush Raises Price Target on IMAX to $46 From $39, Keeps Outperform Rating MT
09/12 Barrington Raises Price Target on IMAX to $42 From $37, Keeps Outperform Rating MT
09/12 B. Riley Raises Price Target on IMAX to $44 From $40, Keeps Buy Rating MT
25/11 Goldman Sachs Upgrades IMAX to Neutral From Sell, Adjusts Price Target to $34 From $22 MT
25/10/25 IMAX Reports 'Superb' Q3 Results, Wedbush Says MT
21/10/25 US Box Office Set to Rebound in Fourth Quarter, B. Riley Says MT
23/09/25 Imax Likely to Surpass 'Peak' EBITDA Margins in Two Years, Wedbush Says MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+30.97%
+20.97%
+19.36%
-0.31%
+8.4%
+8.74%
- -0.34%
Average +12.54%
Weighted average by Cap. +19.19%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
51.60USD
Average target price
56.11USD
Spread / Average Target
+8.74%
High Price Target
69.19USD
Spread / Highest target
+34.09%
Low Price Target
45.00USD
Spread / Lowest Target
-12.79%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
AA
  1. Stock Market
  2. Stocks
  3. IMAX Stock
  4. IMA Stock
  5. Consensus IMAX Corporation
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!